A clinical trial to evaluate the safety and effectiveness of hydroxychloroquine.

A clinical trial to evaluate the safety and effectiveness of hydroxychloroquine for the treatment of adults hospitalized with COVID-19 has begun, with the first participants now enrolled by the National Heart, Lung, and Blood Institute, part of the National Institutes of Health. Hydroxychloroquine is used to treat malaria and rheumatoid conditions such as arthritis. In various studies, the drug has demonstrated antiviral activity, an ability to modify the activity of...

To continue reading

FREE SIGN UP